AMDA On-The-Go | August 2023 | Buprenorphine and Substance Use Disorder...

PALTtalk

Контент предоставлен The Post-Acute and Long-Term Care Medical Association, The Post-Acute, and Long-Term Care Medical Association. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией The Post-Acute and Long-Term Care Medical Association, The Post-Acute, and Long-Term Care Medical Association или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

1y ago 33:36

MP3•Главная эпизода

In this episode of AMDA On The Go, guest host Sabine von Preyss-Friedman welcomes Dr. Jennifer Azen, an expert in Addiction Medicine, to discuss the critical topic of buprenorphine and the treatment of substance use disorder (SUD) in post-acute and long-term care (PALTC). With alarming statistics on drug overdose deaths and the changing landscape of SUD treatment regulations, Dr. Azen shares insights on buprenorphine's effectiveness, its role in pain management, and best practices for practitioners.

Host: Sabine von Preyss-Friedman, MD, FACP, CMD

Guests: Jenn Azen, MD

Recorded: August 4, 2023

Learn more at paltcfoundation.org

Available Credit: The American Board of Post-Acute and Long-Term Care Medicine (ABPLM) issues CMD credits for AMDA On-The-Go and affiliate podcast episodes as follows:

Claim CMD Credit

160 эпизодов

#Society for Post-Acute and Long-Term Care Medicine #Long-Term Care Medicine #Society for Post-Acute #News Director #Podcasting Education